CTEV Claritev Corporation
$35.38▼ -2.91%
Healthcare
Other
Volume 43.1K
Avg Volume (10D) 112.4K
Key Metrics & Fundamentals
Market Cap
$599.60M
P/E Ratio
–
Div Yield
–%
52W Range
11.50 - 73.68
% vs 50 MA
12.38%
% vs 200 MA
29.94%
RSI-14
52.1
MACD Histogram
-0.6300
Beta (1Y vs SPY)
2.30
Free Cash Flow
$54.59M
Gross Rev
$257.48M
Gross Profit
$173.30M
EBITDA
$144.43M
COGS
$84.18M
Operating Exp
$140.33M
Operating Income
$32.97M
EBIT
$32.97M
Pretax Income
-$76.65M
Net Income
-$59.23M
EPS (Diluted)
-3.49
Price & Volume History
Loading chart…
Recent News
Claritev Appoints Ben Letham to its Board of Directors
Business Wire · Sep 15, 2026 1:00 PM
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
Business Wire · Sep 10, 2026 1:00 PM
Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks
Insider Monkey · Sep 8, 2026 2:50 AM
Claritev Corporation Announces Participation in Upcoming Events
Business Wire · Aug 27, 2026 12:00 PM
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Business Wire · Aug 17, 2026 1:00 PM
Claritev (CTEV) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 1:43 PM
Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks
Simply Wall St. · Aug 14, 2026 1:10 AM
Claritev Insider Sold Shares Worth $288,677, According to a Recent SEC Filing
MT Newswires · Aug 12, 2026 8:26 PM
Claritev Corporation Q2 2026 Earnings Call Summary
Moby · Aug 8, 2026 12:30 PM
Claritev Q2 Earnings Call Highlights
MarketBeat · Aug 8, 2026 3:03 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CTEV's money flow as a full page
Social Sentiment
No Reddit posts found for CTEV.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.